Thoracic Surgery Devices Market (2026 - 2033)

Thoracic Surgery Devices Market Summary

The global thoracic surgery devices market was valued at USD 817.1 million in 2025 and is projected to grow from USD 869.0 million in 2026 to USD 1,337.1 million in 2033, at a CAGR of 6.4% from 2026 to 2033. The North America dominated the market, accounting for a revenue share of 39.0% in 2025. The market growth is driven by factors such as the increasing prevalence of conditions like lung cancer, COPD, and heart diseases, continuous innovations in surgical techniques and tools, including minimally invasive options, and the growing aging population.

The growing aging population is a significant growth driver of the market. Elderly people are more susceptible to thoracic conditions, such as lung cancer, esophageal disorders, and heart disease. The elderly population's higher incidence of these diseases is leading to a growing demand for thoracic surgeries and the devices required to perform them effectively. The aging population underscores the importance of patient-centered care and minimally invasive approaches. Elderly patients often prefer procedures that minimize postoperative pain, complications, and lengthy hospital stays. These factors are contributing to the market growth. For instance, in October 2025, UK HealthCare reported increasing cases of lung-related disease and early-stage lung cancer, leading to higher adoption of advanced techniques such as robotic-assisted thoracic surgery (RATS) using the da Vinci SP system. Patients with lung cancer are increasingly being treated with minimally invasive lung resection procedures instead of open thoracotomy due to earlier detection and higher surgical eligibility. Advances in surgical technologies have greatly influenced the growth of the market. Minimally invasive surgical techniques, including video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, have gained popularity due to their reduced invasiveness and faster patient recovery times.

These techniques require specialized devices and instruments designed for precision and efficiency, thereby spurring innovation, and driving the market's expansion. The expansion of healthcare infrastructure, particularly in emerging markets, is contributing to the growth of the market. Improved access to healthcare services, including thoracic surgeries, is increasing the demand for thoracic surgery devices globally. As more healthcare facilities offer thoracic surgical procedures, there is a corresponding increase in the need for devices that aid in diagnosis, treatment, and postoperative care, further propelling market growth.

Analyst Perspective

The thoracic surgery devices market is experiencing steady growth, driven by the increasing prevalence of thoracic disorders, rising incidence of lung cancer and cardiovascular diseases, and growing adoption of minimally invasive surgical procedures. Modernization of thoracic surgery devices in hospitals and specialized surgical centers has helped to achieve higher levels of accuracy, reduce patient recovery period, and improve clinical results. Expansion of healthcare facilities, along with an aging population and awareness about diagnosis and treatment options, has further contributed to the growth of this market. In addition, continuous advancements in surgical instruments, imaging technologies, and robotic-assisted surgical systems are improving procedural efficiency and safety. Furthermore, increasing demand for minimally invasive and precise surgeries, companies that invest in innovation and technology would reap benefits from future growth.

Product Insights

The forceps segment held the largest market share of over 26.0% in 2025. Forceps are versatile surgical instruments used in a wide range of medical procedures, including thoracic surgery. They are essential for grasping, holding, manipulating, and dissecting tissues, making them indispensable tools for thoracic surgeons. Moreover, thoracic surgeries often require precise and delicate tissue handling. Forceps provide surgeons with the fine control needed to perform intricate procedures, minimizing the risk of damage to surrounding structures. The rising development in minimally invasive thoracic surgeries is also contributing significantly towards the adoption of specialized forceps. Furthermore, the rising number of thoracic surgeries across the globe will ensure the high adoption of forceps in surgical procedures.

The stapler segment is expected to grow at the fastest CAGR over the forecast period. The adoption of minimally invasive surgical techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, has been on the rise. Staplers are essential tools for creating secure and precise anastomoses or connections within the thoracic cavity during these minimally invasive procedures. For instance, in June 2025, Johnson & Johnson MedTech launched the ETHICOM 4000 Stapler, an advanced surgical stapling system designed to improve staple-line security through 3D Stapling Technology and enhanced tissue handling features. Their use reduces the need for hand suturing, leading to quicker, more efficient surgeries and shorter patient recovery times. Such advantages associated with staplers are anticipated to foster segment growth.

Surgery Type Insights

The lobectomy segment held the largest market share of over 43.0% in 2025. The segment growth is attributed to the growing prevalence of lung cancer globally, and lobectomy is a primary treatment option for early-stage lung cancer. Given the high incidence of lung cancer, the demand for lobectomy procedures and associated devices is substantial. Moreover, lobectomy is considered the gold standard treatment for localized lung cancer. It offers the best chance of curing the disease while preserving adequate lung function. In addition, increasing adoption of minimally invasive and video-assisted thoracic surgical (VATS) techniques is further enhancing procedural efficiency and patient recovery outcomes. Furthermore, continuous advancements in surgical instruments and perioperative care are expected to support the sustained growth of the lobectomy segment.

The wedge resection segment is expected to grow at the fastest CAGR over the forecast period. The adoption of minimally invasive surgical techniques, including video-assisted thoracoscopic surgery (VATS), has expanded the use of wedge resection. These techniques reduce patient trauma, lead to shorter hospital stays, and enable faster recovery, making them attractive options for both patients and surgeons. In addition, growing inclination towards lung-sparing surgical procedures for the treatment of early-stage cancers is fueling the market growth. Furthermore, growing advancements in thoracic surgery devices and imaging modalities are contributing to the growth of this segment.

End-use Insights

The hospital segment held the largest market share of approximately 46.0% in 2025. Hospitals are the preferred choice for treating severe thoracic conditions, such as advanced-stage lung cancer, complicated cardiovascular diseases, and trauma cases. These conditions often require extensive resources, advanced technologies, and a multidisciplinary approach, which hospitals can offer. The rising number of thoracic surgeries taking place in the hospital setup is driving the requirement for advanced surgical equipment and operating rooms. In addition, there has been an increasing investment by hospitals in minimally invasive surgery techniques to ensure better patient care and efficiency.

The ambulatory surgical centers segment is expected to grow at the fastest CAGR over the forecast period. ASCs are designed for outpatient surgical procedures, and there is a growing trend toward performing thoracic surgeries in these facilities. Patients prefer ASCs for same-day surgeries, convenience, and shorter wait times. In addition, the trend towards outpatient surgery is facilitating better resource use and quicker recovery in health care systems. There have been developments in minimally invasive surgeries of the thorax.

Regional Insights

North America dominated the thoracic surgery devices market, accounting for approximately 39.0% of revenue in 2025. The growth can be attributed to its advanced healthcare infrastructure, technological leadership, rising disease incidence, aging population, robust healthcare spending, commitment to R&D, skilled healthcare workforce, rigorous regulatory standards, and patient awareness and access. These factors collectively establish North America as a prominent and thriving hub for thoracic surgical care and associated devices.

In addition, the presence of prominent medical device manufacturers and early adoption of minimally invasive surgical devices have contributed to the regional market growth. Furthermore, constant improvements in the hospital infrastructure and healthcare systems based on innovation are anticipated to maintain the dominant position of North America in the thoracic surgery devices market. Several significant developments are taking place in the market supporting the growth of thoracic surgery devices. For instance, in March 2025, Cook Medical announced commercial availability of the Zenith Alpha 2 Thoracic Endovascular Graft (ZTA2) in the U.S. after FDA approval. The device is designed for thoracic endovascular procedures and includes updated deployment features to support aortic repair procedures.

Asia Pacific Thoracic Surgery Devices Market Trends

The Asia Pacific market is expected to grow at the fastest CAGR over the forecast period. Rising disposable incomes and expanding healthcare coverage in some Asia Pacific countries have led to increased healthcare spending. Patients have greater access to advanced diagnostic and treatment options, including thoracic surgeries, contributing to market growth. In addition, the rising trend of minimally invasive surgeries. In addition, rapid urbanization and the development of healthcare infrastructure facilities are helping patients gain access to advanced facilities in the thoracic field. Furthermore, rising investments from both public and private sectors in healthcare modernization are strengthening market expansion. Growing awareness about early disease diagnosis and treatment is further driving the demand for thoracic surgery devices in the region

Key Thoracic Surgery Devices Insights

The thermoplastic polyester elastomer market is moderately competitive, with the presence of global chemical manufacturers and specialty polymer producers focusing on material innovation and application expansion. Companies in the market are constantly investing in R&D activities to introduce innovative designs and technologies.

Key Thoracic Surgery Devices Companies

The following key companies have been profiled for this study on the thoracic surgery devices market:

• Medtronic

• Cardio medical GmbH

• Intuitive Surgical Operations, Inc.

• Richard Wolf GmbH

• Grena Limited

• Teleflex Incorporated

• Medela

• LivaNova PLC

• Sklar Corporation

• Karl Storz SE & Co. KG

Recent Developments

• In July 2025, Teleflex completed the acquisition of BIOTRONIK's Vascular Intervention business for approximately USD 871.4 million. The acquisition expands Teleflex's interventional portfolio and strengthens its presence in catheter-based and minimally invasive procedures, supporting broader cardiovascular and thoracic intervention capabilities.

• In August 2024, KARL STORZ completed the acquisition of Asensus Surgical to strengthen its digital surgery and robotic-assisted surgery portfolio. The acquisition enhances KARL STORZ's capabilities in minimally invasive and robot-assisted procedures, creating opportunities across thoracic, laparoscopic, and endoscopic surgery applications.

Thoracic Surgery Devices Market Report Scope

Global Thoracic Surgery Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global thoracic surgery devices market report by product, surgery type, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Clamps
  • Forceps
  • Graspers
  • Staplers
  • Scissors
  • Spreaders
  • Needle Holders
  • Others
• Surgery Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Lobectomy
  • Wedge Resection
  • Pneumonectomy
  • Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE